Core Insights - Canadian cannabis firms with U.S. exposure are gaining attention due to their ability to bridge both markets, which positions them advantageously as U.S. policy shifts may provide new momentum for growth [1][2][24] - The U.S. legal cannabis market is projected to grow from approximately $37 billion in 2024 to over $91 billion by 2033, indicating a strong annual growth rate of more than 10 percent [2][24] - Recent headlines regarding potential federal reclassification of marijuana have fueled optimism, leading to a rally in cannabis stocks as traders seek follow-through momentum [3][24] Company Summaries Tilray - Tilray is one of the largest cannabis companies globally, focusing on cannabis-adjacent consumer goods in the U.S., with its beverage division being a key growth driver [5][6] - The company reported annual revenue exceeding $820 million, but also a significant net loss of over $2 billion, highlighting the need for tighter cost control despite strong performance in certain divisions [9][11] - The beverage segment achieved gross margins of around 40 percent, indicating strong consumer demand and pricing power [10] Village Farms International - Village Farms operates large-scale greenhouses, supplying cannabis in both Canada and the U.S., with a focus on efficient production rather than retail [12][14] - The company emphasizes wholesale supply to licensed retailers, which reduces capital costs and lowers risk while controlling significant production volumes [12][14] - Recent financial results show steady progress, with Canadian cannabis sales increasing year over year, benefiting from rising demand and improving margins [15][16] Canopy Growth - Canopy Growth is known for its broad product portfolio, including flower, pre-rolls, edibles, and wellness products, and has a presence in the U.S. through licensing and partnerships [17][20] - The company reported strong growth in Canadian medical cannabis sales, reaching $77 million, while international sales showed slight declines [21][22] - Canopy's gross margins expanded by 300 basis points year over year, and it reduced total debt by nearly 50 percent, indicating progress in strengthening its balance sheet [21][22] Market Outlook - The U.S. cannabis market's expansion presents significant opportunities for Canadian firms with U.S. exposure, particularly as potential rescheduling of marijuana could reduce restrictions and enhance valuations [2][24] - Volatility in the sector remains high, making technical analysis and risk management essential for investors looking to participate in the growth story [4][25]

Group 1 - Alan Brochstein is a pioneer in the cannabis investment sector, having focused exclusively on this industry since 2007 [1] - He founded AB Analytical Services to provide independent consulting to registered investment advisors [1] - Brochstein is the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1] Group 2 - Alan has led the investing group 420 Investor since 2013, which focuses on publicly-traded cannabis stocks [2] - The group covers 20 stocks, providing investment news, earnings report previews, and post-report analyses [2] - Additional features of the group include a model portfolio, 10 weekly videos with chart analysis, 3 weekly summary pieces, a monthly newsletter, and a chat for questions [2]

Industry Overview - Recent trading activity in marijuana stocks has increased, driven by discussions of federal reform by President Donald Trump, which is expected to advance the public sector and the industry as a whole [1][2] - There is growing speculation that the passage of federal reform will lead to consistent upward trading in the sector, boosting investor confidence [2] Company Highlights - **Verano Holdings Corp.**: Operates as a vertically integrated multi-state cannabis operator in the U.S. Recently announced the resignation of President Darren Weiss to pursue opportunities outside North America [4][5] - **Glass House Brands Inc.**: An integrated cannabis company operating in retail, wholesale biomass, and cannabis-related consumer packaged goods. Reported Q2 2025 earnings [5][6] - **Ayr Wellness Inc.**: Cultivates, manufactures, and retails cannabis products. Announced a restructuring support agreement with senior noteholders to ensure continued operations under new ownership [8][10] Financial Performance - **Glass House Brands Inc. Q2 2025 Results**: - Revenue of $59.9 million, an increase of 11% from $53.9 million in Q2 2024 and up 34% from $44.8 million in Q1 2025 [11] - Gross Profit of $31.9 million, compared to $28.7 million in Q2 2024 and $20.1 million in Q1 2025 [11] - Gross Profit Margin maintained at 53% [11] - Adjusted EBITDA of $18.1 million, up from $12.4 million in Q2 2024 and $4.4 million in Q1 2025 [11] - Positive Operating Cash Flow of $17.7 million, compared to $8.9 million in Q2 2024 and $2.5 million in Q1 2025 [11] - Equivalent Dry Pound Production of 230,748 pounds, a 54% year-over-year increase [11] - Cost per Equivalent Dry Pound of Production decreased by 39% to $91 per pound [11] - Cash, Restricted Cash, and Cash Equivalents balance of $44.2 million at quarter-end, up from $37.6 million at the end of Q1 2025 [11]

Core Insights - EnWave Corporation will report its financial results for Q3 2025 on August 21, 2025, after market close [1] - A conference call to discuss the results and business outlook is scheduled for August 22, 2025, at 7:00 a.m. Pacific Time [2][3] Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a patented Radiant Energy Vacuum (REV™) technology [4] - The company serves various industries, including food, pharmaceuticals, and cannabis, offering a drying solution that outperforms traditional methods in efficiency, capacity, product quality, and cost [4] Business Strategy - EnWave aims to sign royalty-bearing commercial licenses with food producers to enhance their drying processes, achieving optimal moisture levels up to seven times faster than conventional methods [6] - The company has over fifty partners across twenty-four countries, enabling them to create innovative snacks and ingredients while improving existing product quality and market speed [5]

Core Insights - EnWave Corporation will report its financial results for Q3 2025 on August 21, 2025, after market close [1] - A conference call to discuss the results and business outlook is scheduled for August 22, 2025, at 7:00 a.m. Pacific Time [2][3] Company Overview - EnWave is a leader in vacuum microwave dehydration technology, with a strong intellectual property portfolio and a patented Radiant Energy Vacuum (REV™) technology [4] - The company serves various industries, including food, pharmaceuticals, and cannabis, offering a drying solution that outperforms traditional methods in efficiency, capacity, product quality, and cost [4] Business Strategy - EnWave aims to sign royalty-bearing commercial licenses with food producers to enhance drying processes, enabling faster production and improved product quality [6] - The company has over fifty partners across twenty-four countries, helping them create innovative snacks and ingredients while improving existing product offerings [5]

Financial Performance - Company reported revenue of $4.6 million for the third quarter of fiscal 2025, a decrease of 10.9% from $5.2 million in the same period last year [2][12] - Operating loss increased to $0.9 million from $0.4 million in the prior year [2][12] - Year-to-date revenues decreased slightly from $14.9 million to $14.5 million [12] Strategic Developments - Major overhaul of the marketing team and digital strategy has been completed to address the revenue decline [3] - The beverage brand, Oasis, has expanded distribution to 7 states, with e-commerce growth accelerating since July [3][7] - Company is actively engaging with industry associations and legislators to navigate regulatory changes impacting wholesale partners [3][4] Regulatory Environment - Recent positive developments at the national level include progress on the farm bill and cannabis scheduling discussions from the White House [4] - Increased regulatory scrutiny is expected to favor compliant brands and may drive industry consolidation, presenting opportunities for the company [4] Financial Position - As of June 30, 2025, the company had working capital of approximately $2.0 million and cash on hand of approximately $1.1 million, an improvement from a working capital deficit of $2.2 million the previous year [12] - The book value of equity increased significantly from $0.67 million to approximately $6.1 million following the conversion of Series A Preferred Stock [7] Sales Breakdown - Direct-to-consumer (DTC) net sales accounted for 78% of total net sales in the third quarter, totaling $3.6 million, compared to $3.9 million or 76% in the prior year [12] - Wholesale net sales were $1.0 million, representing 22% of total net sales, down from $1.2 million in the same quarter last year [12]

Group 1 - Alan Brochstein is a pioneer in the cannabis investment sector, having focused exclusively on this industry since 2007 [1] - He founded AB Analytical Services to provide independent consulting to registered investment advisors [1] - Brochstein is the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1] Group 2 - Alan has led the investing group 420 Investor since 2013, which focuses on publicly-traded cannabis stocks [2] - The group covers 20 stocks, providing investment news, earnings report previews, and post-report analyses [2] - Additional features of the group include a model portfolio, 10 weekly videos with chart analysis, 3 weekly summary pieces, a monthly newsletter, and a chat for questions [2]

Core Insights - MJBizCon and Budist are launching the MJBowl, a bi-coastal competition to highlight the Most Valuable Products (MVP) from California and New York across five categories, with winners announced on December 4 [1][5] - The competition runs from August 14 to October 3, 2025, and is open to licensed cannabis companies in the respective states [2] - Judging will be conducted by Budist's panel of critics using a standardized scoring rubric to ensure credibility, with winning brands featured in consumer judging kits [3][4] Industry Context - The MJBowl aims to bridge the gap between East and West cannabis markets, promoting product excellence and national recognition for the cannabis industry [5] - Budist is positioned as a professional review platform, enhancing transparency and community engagement in cannabis product evaluations [8] - MJBiz is recognized as a leading B2B resource for the cannabis industry, producing the largest cannabis trade show, MJBizCon, which has been consistently ranked among the top trade shows in the U.S. [7]

Core Insights - Auxly Cannabis Group Inc. reported a record quarter with significant increases in net revenue, gross profit, and Adjusted EBITDA, indicating strong demand and operational efficiencies in the cannabis market [4][9][26] Financial Highlights - Net revenues for Q2 2025 reached $38.8 million, a 33% increase from $29.2 million in Q2 2024 [5][9] - Gross margin on finished cannabis inventory sold improved to 52% in Q2 2025 from 41% in Q2 2024, reflecting enhanced production efficiencies [6][11] - Adjusted EBITDA for Q2 2025 was $11.5 million, representing a 123% increase year-over-year [6][26] - Net income for Q2 2025 was $8.3 million, a 315% increase compared to $2.0 million in Q2 2024 [6][24] Operational Performance - The company maintained a gross profit of $22.7 million for Q2 2025, up from $15.9 million in Q2 2024, resulting in a gross profit margin of 58% [11][24] - Selling, general, and administrative expenses (SG&A) were $10.3 million in Q2 2025, an 11% increase from the previous year, driven by investments to support higher sales [13][18] - The company reported cash flow from operations of $4 million and had $17 million in cash at the end of the quarter [6][9] Market Position - Auxly is the third-largest licensed producer in Canada with a market share of 6.2% [6] - The company’s product portfolio includes a strong performance in dried flower and pre-roll cannabis products, which accounted for approximately 65% of sales in Q2 2025 [10][11] Strategic Outlook - The company plans to allocate $1.5 million to $2.5 million of cash flow from operations towards capital projects in 2025, with excess cash flow aimed at strengthening the balance sheet [30][32] - Auxly is focused on sustainable growth through innovation and operational excellence, positioning itself to capitalize on the expanding Canadian recreational cannabis market [27][28]

Core Viewpoint - Cannara Biotech Inc. successfully completed the sale of a non-core building and land for $5.5 million, aligning with its asset optimization strategy and enhancing its financial position [1][2][4]. Group 1: Transaction Details - The sale involved a building under construction and a related parcel of land at the Valleyfield site, which had a carrying value of approximately $4.95 million as of May 31, 2025 [2]. - The net proceeds from the sale amount to $5.45 million, which will be used to reduce the principal balance of Cannara's existing term loan, thereby decreasing long-term debt [3]. Group 2: Strategic Implications - This transaction is part of Cannara's broader strategy to unlock value from underutilized assets while maintaining financial flexibility [4]. - The reduction of debt by $5.45 million is expected to enhance Cannara's capital structure and support future margin expansion [4]. - The company aims to create long-term shareholder value by aligning resources with its core business and growth trajectory [4].